Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Quantum-Si
AddedFeb 19, 2024
UpdatedJun 18, 2026
Quantum-Si

Quantum-Si

Public

Quantum-Si: A unique space empowering bright minds to solve tough problems and pioneer new science.

HQ
Guilford, CT, US
Founded
2013
Overview
Compare
Fundraising
Employees
News
Website

Quantum-Si, founded with the mission to revolutionize proteomics, aims to empower scientific discovery through advanced technology. Their core vision is to democratize access to single-molecule protein sequencing, enabling every lab to delve deeper into protein analysis. The company offers the Platinum® benchtop sequencer, a pioneering Next-Generation Protein Sequencer™ that detects single amino acids with high sensitivity. This innovative tool is designed to provide groundbreaking insights into protein variants, making it a valuable asset in the field of proteomics.

Notable figures associated with Quantum-Si include leading scientists and industry experts who bring a wealth of knowledge and experience to the company. The startup has attracted significant investment from prominent venture capital firms, underscoring its potential impact on the scientific community. Key achievements include being the first to market with their advanced protein sequencing technology, which has already begun transforming research capabilities in labs worldwide. Quantum-Si's contributions are setting new standards in proteomics, fostering a deeper understanding of proteins and their functions.

Quantum-Si - Similar Companies

Erisyon logo

Erisyon

erisyon.com

Glyphic Biotechnologies logo

Glyphic Biotechnologies

glyphic.bio

Phasiq logo

Phasiq

Seer logo

Seer

seer.bio

Quantapore logo

Quantapore

SeqLL logo

SeqLL

seqll.com

Encodia logo

Encodia

encodia.com

Sequegenics logo

Sequegenics

sequegenics.com

Spear Bio logo

Spear Bio

spear.bio

Q Biotech logo

Q Biotech

q-biotech.com

Parse Biosciences logo

Parse Biosciences

ProteoWise logo

ProteoWise

proteowise.com

Pacific Biosciences of California logo

Pacific Biosciences of California

10x Genomics logo

10x Genomics

10xgenomics.com

Quanterix logo

Quanterix

Quantum-Si - Quick Facts

Who are Quantum-Si's competitors?

Companies similar to Quantum-Si include Erisyon, Glyphic Biotechnologies, Phasiq and Seer.

When was Quantum-Si founded?

Quantum-Si was founded in 2013.

Where is Quantum-Si's headquarters located?

Quantum-Si's headquarters is located in Guilford, CT, US.

When was Quantum-Si's last funding round?

Quantum-Si's most recent funding round was for $425M (USD) in June 2021.

How much has Quantum-Si raised to-date?

As of Jun 11, 2021, Quantum-Si has raised a total of $425M (USD).

How many employees does Quantum-Si have?

Quantum-Si has 196 employees as of Feb 6, 2024.

Quantum-Si - Classification

Industry
  • Hardware
Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Protein Sequencing
Tags
  • Data
  • Research
Unique IDs
  • secCik: 0001816431
  • ticker: QSI
  • ticker: QSIAW
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 3820Laboratory Apparatus And Analytical, Optical, Measuring, And Control
  • 3829Measuring and Controlling Devices, Not Elsewhere Classified
ISIC
  • 3250Manufacture of medical and dental instruments and supplies
Show 29 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 334500Navigational, Measuring, Electromedical, and Control Instruments Manufacturing
  • 334510Navigational, Measuring, Electromedical, and Control Instruments Manufacturing
  • 334514Totalizing Fluid Meter and Counting Device Manufacturing
  • 334519Other Measuring and Controlling Device Manufacturing
  • 339100Medical Equipment and Supplies Manufacturing
  • 339110Medical Equipment and Supplies Manufacturing
  • 339112Surgical and Medical Instrument Manufacturing
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 334000Computer and Electronic Product Manufacturing
  • 339000Miscellaneous Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 4000Railroad Transportation
  • 5000Wholesale Trade-durable Goods
  • 6700Holding And Other Investment Offices
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research